Ibogaine

A Study of Oral Ibogaine in Opioid Withdrawal and Relapse Prevention

Ibogaine, a transformative psychedelic medicine, shows promise in treating addiction by altering perception and mood. With a long history of use, it is now being tested in clinical trials.

PS2023 Ancestral Knowledge Ibogaine Indigenous People Policy and Advocacy Research Substance Use Disorder

A conversation with Norma Lotsof

Norma Lotsof is a pioneering advocate of ibogaine treatment, working with her husband Howard Lotsof to promote its therapeutic potential worldwide, particularly in interrupting opiate addiction. Norma continues to advocate

Norma Lotsof, Lucy Walker

PS2023 Anxiety Depression Ibogaine PTSD Research Veterans

Ibogaine-Magnesium: the Stanford Traumatic Injury to the CNS (MISTIC) Protocol – A Pilot Study in Special Operations Veterans with Traumatic Brain Injuries

Stanford conducted the first trial of Magnesium-Ibogaine on Special Operations Forces Veterans with traumatic brain injury, showing significant functional improvements and high remission rates for comorbid psychiatric disorders. Further controlled

Nolan Williams

PS2023 Harm Reduction Health Conditions Ibogaine Psychedelic Science Research Substance Use Disorder

Preliminary results from a Pilot study of the efficacy and safety of ibogaine in the treatment of methadone detoxification

Study on ibogaine for methadone dependence treatment aims to establish safe detox protocol through first Phase-II trial. Weekly low-dose evaluations conducted to gather safety and efficacy data for future research.

Jose Carlos Bouso

PS2023 Ayahuasca Healing for All Ibogaine Plant Medicine Policy and Advocacy Psilocybin

How Colorado is Building a Careful Revolution in Psychedelic Healing

Colorado becomes first state to regulate access to psilocybin, ayahuasca, mescaline, and ibogaine after passing Natural Medicine Health Act. Christiana Musk interviews Senate President Fenberg on implications and challenges.

Christiana Musk, Steve Fenberg